Violante E. Currie

3.7k citations

41 papers · 2.6k indexed · h-index 25

Impact in

Oncology top 1%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer survivorship and care
Cancer Research top 5%
- Breast Cancer Treatment Studies

Papers in

Dermatology 12
- Chemotherapy-related skin toxicity 12
Oncology 29
- Cancer Treatment and Pharmacology 20
- HER2/EGFR in Cancer Research 8
- Colorectal Cancer Treatments and Studies 3
- Neutropenia and Cancer Infections 3
- Cancer survivorship and care 3

Co-authors: Andrew D. Seidman Clifford A. Hudis John Crown T. Hakes Larry Norton William H. Redd Richard J. Kaufman Maria Theodoulou
Journals: Journal of Clinical Oncology (9 papers)Cancer (6 papers)Annals of the New York Academy of Sciences (3 papers)Oncology (2 papers)Journal of the American Geriatrics Society (1 paper)
Partner nations: United States United Kingdom Canada

In The Last Decade

Violante E. Currie

41 papers receiving 2.4k citations

Peers

Countries citing papers authored by Violante E. Currie

Since Specialization

Citations

This map shows the geographic impact of Violante E. Currie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Violante E. Currie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Violante E. Currie more than expected).

Fields of papers citing papers by Violante E. Currie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Violante E. Currie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Violante E. Currie. The network helps show where Violante E. Currie may publish in the future.

Co-authors

The 25 scholars most cited alongside Violante E. Currie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Violante E. Currie Line = papers co-authored together Violante E. Currie links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Practical guidelines for routine intensity-modulated radiotherapy verification: pre-treatment verification with portal dosimetry and treatment verification within vivodosimetry British Journal of Radiology ·Paul A. Starosta, A. Williams, Violante E. Currie, A. Van Esch, D. Huyskens	2010	29
2	Social Support, Intrusive Thoughts, and Quality of Life in Breast Cancer Survivors Journal of Behavioral Medicine ·楊麗麗, Sharon L. Manne, Katherine N. DuHamel, Kaila Naulia, Dana H. Bovbjerg, Violante E. Currie, Gary Winkel, William H. Redd	2001	85
3	Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma. PubMed ·P. Aswathy, Andrew D. Seidman, Maria Theodoulou, Mary Ellen Moynahan, Violante E. Currie, Mark M. Moasser, Ahmed K. Shawush, Theresa Gilewski, Gabriella D’Andrea, Rori Salvaggio, K. Panageas, Larry Norton, Clifford A. Hudis	2001	25
4	Intrusive Thoughts and Psychological Distress Among Breast Cancer Survivors: Global Meaning as a Possible Protective Factor Behavioral Medicine ·Suzanne M. Johnson Vickberg, Dana H. Bovbjerg, Katherine N. DuHamel, Violante E. Currie, William H. Redd	2000	86
5	Lack of Increased Cardiac Toxicity with Sequential Doxorubicin and Paclitaxel Cancer Investigation ·Clifford A. Hudis, 王林 Wang Lin, Andrew D. Seidman, José Baselga, Violante E. Currie, D. Fennelly, Teresa Gilewski, David Lebwohl, Mary Ellen Moynahan, George Raptis, Antonella Surbone, Nancy T. Sklarin, Tzy‐Jyun Yao, Deborah Keefe, Larry Norton	1998	9
6	Patients' pretreatment expectations of chemotherapy-related nausea are an independent predictor of anticipatory nausea Annals of Behavioral Medicine ·Guy H. Montgomery, Naomi Tomoyasu, Dana H. Bovbjerg, Michael A. Andrykowski, Violante E. Currie, Paul B. Jacobsen, William H. Redd	1998	58
7	Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer. Journal of Clinical Oncology ·Andrew D. Seidman, Clifford A. Hudis, J. Albanell, Ronald F. Lopez, W P Tong, I Tepler, Violante E. Currie, Mary Ellen Moynahan, Maria Theodoulou, Marc J. Gollub, José Baselga, Larry Norton	1998	318
8	Phase II study of semisynthetic paclitaxel in metastatic breast cancer European Journal of Cancer ·Clifford A. Hudis, Kai Jiang, Frankie A. Holmes, Andrew D. Seidman, José Baselga, Violante E. Currie, D. Fennelly, Teresa Gilewski, Mary Ellen Moynahan, George Raptis, Nancy T. Sklarin, Antonella Surbone, Mary Uhlenhopp, Tasya Eka Putri, T. J. Yao, P Cozza, Amanda Garcia Higa, Gabriel N. Hortobágyi, Larry Norton	1997	5
9	Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer. Journal of Clinical Oncology ·Andrew D. Seidman, Daniel Hochhauser, Milena Emanuela Nascimento Lima, George E. Henry, Tzy‐Jyun Yao, Clifford A. Hudis, Prudence A. Francis, D. Fennelly, Theresa Gilewski, Mary Ellen Moynahan, Violante E. Currie, José Baselga, W P Tong, B. Z. Phutkaradze, Rori Salvaggio, Louis‐Joseph Auguste, David R. Spriggs, Larry Norton	1996	138
10	Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer. Journal of Clinical Oncology ·C. Hudis, Andrew D. Seidman, John Crown, Casilda Balmaceda, Ronnie J. Freilich, Teresa Gilewski, T. Hakes, Violante E. Currie, David Edward Lebwohl, José Baselga, George Raptis, Milena Emanuela Nascimento Lima, Thomas Berger, René Bruno, Larry Norton	1996	127
11	Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer. Journal of Clinical Oncology ·Andrew D. Seidman, Amy Tiersten, Clifford A. Hudis, Milena Emanuela Nascimento Lima, Sophie Barrett, T. J. Yao, J. McCarthy Lepore, Teresa Gilewski, Violante E. Currie, John Crown	1995	177
12	Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response. Journal of Clinical Oncology ·Andrew D. Seidman, Bonnie Reichman, John Crown, Tzy‐Jyun Yao, Violante E. Currie, T. Hakes, Clifford A. Hudis, Theresa Gilewski, José Baselga, Paul Forsythe	1995	180
13	Protein binding of brequinar in the plasma of healthy donors and cancer patients and analysis of the relationship between protein binding and pharmacokinetics in cancer patients Cancer Chemotherapy and Pharmacology ·Shang‐Ying P. King, Ruben Boluda Ruiz, Huang Mai-hua, Elizabeth Hetterly, David B. Adams, Violante E. Currie, Joseph R. Bertino, Henry J. Pieniaszek, Check Y. Quon	1994	5
14	Taxol (Paclitaxel) plus Recombinant Human Granulocyte Colony-Stimulating Factor in the Treatment of Metastatic Breast Cancer Oncology ·Andrew D. Seidman, Larry Norton, Bonnie Reichman, John Crown, T. J. Yao, Thomas B. Hakes, David Lebwohl, Theresa Gilewski, Clifford A. Hudis, Antonella Surbone, Violante E. Currie, Raymond W. Klecker, Carlos Jamis‐Dow, Jerry M. Collins, Salwa Dawood Hama- Ameen, Kathryn A. LaPerrier, 貴子信川, Renzo Canetta, Nicole Onetto, Susan G. Arbuck	1994	2
15	Taxol and Recombinant Human Granulocyte Colony‐Stimulating Factor, an Active Regimen as Initial Therapy for Metastatic Breast Cancer Annals of the New York Academy of Sciences ·Bonnie Reichman, Andrew D. Seidman, John Crown, Robert T. Heelan, T. J. Yao, Thomas B. Hakes, David Lebwohl, Theresa Gilewski, Antonella Surbone, Violante E. Currie, Clifford A. Hudis, Kathryn A. LaPerrier, 貴子信川, 瑞穂北村, Renzo Canetta, Jason S. Fisherman, Susan G. Arbuck, Larry Norton	1993	2
16	Phase II trial of carboplatin and etoposide in metastatic breast cancer Cancer ·Fukukazu KONDO, Thomas Hakes, Bonnie Reichman, David Lebwohl, Theresa Gilewski, Antonella Surbone, Violante E. Currie, Tzy‐Jyun Yao, Clifford A. Hudis, Andrew D. Seidman, Larry Norton	1993	10
17	Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer. Journal of Clinical Oncology ·Bonnie Reichman, Andrew D. Seidman, John Crown, R T Heelan, T. Hakes, David Edward Lebwohl, Teresa Gilewski, Antonella Surbone, Violante E. Currie, Clifford A. Hudis	1993	207
18	Association of disease-free survival and percent of ideal dose in adjuvant breast chemotherapy Cancer ·Nancy L. Geller, Thomas B. Hakes, Gina R. Petroni, Violante E. Currie, Richard J. Kaufman	1990	9
19	Nonpharmacologic factors in the development of posttreatment nausea with adjuvant chemotherapy for breast cancer Cancer ·Paul B. Jacobsen, Muhammad Musa Alafarizi, Jimmie C. Holland, Michael A. Andrykowski, William H. Redd, Thomas B. Hakes, Richard J. Kaufman, Violante E. Currie	1988	69
20	Prevalence, predictors, and course of anticipatory nausea in women receiving adjuvant chemotherapy for breast cancer Cancer ·Michael A. Andrykowski, Paul B. Jacobsen, Urbano Jiménez F, Kenneth Gorfinkle, Thomas B. Hakes, Richard J. Kaufman, Violante E. Currie, Jimmie C. Holland, William H. Redd	1988	68

About Violante E. Currie

Violante E. Currie is a scholar working on Dermatology, Oncology, Cancer Research, Geriatrics and Gerontology and Pharmacy, having authored 41 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (20 papers), Chemotherapy-related skin toxicity (12 papers), HER2/EGFR in Cancer Research (8 papers), Breast Cancer Treatment Studies (8 papers), Nausea and vomiting management (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Neutropenia and Cancer Infections (3 papers) and Cancer survivorship and care (3 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (636 citations), Dermatology (282 citations), Complementary and alternative medicine (137 citations) and Pulmonary and Respiratory Medicine (449 citations). Violante E. Currie has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Andrew D. Seidman, Clifford A. Hudis, John Crown, T. Hakes, Larry Norton, William H. Redd, Richard J. Kaufman, Maria Theodoulou, Teresa Gilewski and Mary Ellen Moynahan. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Annals of the New York Academy of Sciences, Oncology and Journal of the American Geriatrics Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact